Phase I/II clinical trial of gene therapy for hormone refractory metastatic prostate cancer

被引：0
|
作者：
Gotoh, A [1 ]
Terao, S [1 ]
Shirakawa, T [1 ]
机构：
[1] Kobe Univ, Sch Med, Int Ctr Med Res & Treatment, Kobe, Hyogo 6500017, Japan
来源：
JOURNAL OF GENE MEDICINE | 2006年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：371 / 372
页数：2
相关论文
共 50 条
  • [31] A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer
    Pienta, KJ
    Redman, BG
    Bandekar, R
    Strawderman, M
    Cease, K
    Esper, PS
    Naik, H
    Smith, DC
    UROLOGY, 1997, 50 (03) : 401 - 406
  • [32] A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer
    Goodin, S
    Rao, KV
    Kane, M
    Dave, N
    Capanna, T
    Doyle-Lindrud, S
    Engle, E
    Jin, LX
    Todd, M
    DiPaola, RS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (02) : 199 - 204
  • [33] A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer
    Susan Goodin
    Kamakshi V. Rao
    Michael Kane
    Nisha Dave
    Terry Capanna
    Susan Doyle-Lindrud
    Elizabeth Engle
    Lixian Jin
    Mary Todd
    Robert S. DiPaola
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 199 - 204
  • [34] In situ gene therapy for adenocarcinoma of the prostate:: A phase I clinical trial
    Herman, JR
    Adler, HL
    Aguilar-Cordova, E
    Rojas-Martinez, A
    Woo, S
    Timme, TL
    Wheeler, TM
    Thompson, TC
    Scardino, PT
    HUMAN GENE THERAPY, 1999, 10 (07) : 1239 - 1249
  • [35] Phase II trial of a GM-CSF gene-transduced prostate cancer cell line vaccine in hormone refractory prostate cancer
    Ando, D
    Simons, J
    Nelson, W
    Nemunaitis, J
    Centeno, A
    Dula, E
    Urba, W
    Howard, C
    Small, E
    JOURNAL OF UROLOGY, 2003, 169 (04): : 396 - 396
  • [36] Cancer gene therapy with a retrovirally transduced IL2-IFNγ-secreting allogeneic tumorvaccine in patients with progressive hormone refractory prostate cancer-A phase I/II trial
    Gansbacher, B.
    Brill, T.
    Eisele, B.
    Kuebler, H.
    van Randenborgh, H.
    Paul, R.
    Hartung, R.
    Fend, F.
    Pohla, H.
    Schendel, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Interleukin 2 gene therapy for prostate cancer: Phase I clinical trial and basic biology
    Belldegrun, A
    Tso, CL
    Zisman, A
    Naitoh, J
    Said, J
    Pantuck, AJ
    Hinkel, A
    de Kernion, J
    Figlin, R
    HUMAN GENE THERAPY, 2001, 12 (08) : 883 - 892
  • [38] Focal Therapy for Localized Prostate Cancer: A Phase I/II Trial
    Ahmed, H. U.
    Freeman, A.
    Kirkham, A.
    Sahu, M.
    Scott, R.
    Allen, C.
    Van der Meulen, J.
    Emberton, M.
    JOURNAL OF UROLOGY, 2011, 185 (04): : 1246 - 1254
  • [39] A phase I/II study of adenovirus-mediated interleukin-12 gene therapy for hormone refractory prostate cancer: An interim report
    Sasaki, K.
    Nasu, Y.
    Kaku, H.
    Watanabe, M.
    Nose, H.
    Kanbara, D.
    Saika, T.
    Kumon, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [40] Phase II study of oral vinorelbine plus hormone therapy in hormone-refractory prostate cancer
    Chiti, F.
    Calais da Silva, F. M.
    Canelas, A.
    Goncalves, P.
    Gomes, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345